Glucagon Kit
Product Images NDC 69097-027

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 69097-027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box-back-label-kit (Box Back Label Kit)

The image shows the back label of a Glucagon injection kit by Cipla USA Inc. It includes usage instructions stating the kit contains one single-dose vial of glucagon for injection (USP, 1 mg) and one 1-mg diluent vial. It also features directions for mixing and administration, medication storage instructions, and a warning not to remove the slipcover from the vial. There is a designated area for batch overprinting including serial number, expiry date, and lot number. Barcodes and regulatory text are present as well.*

FDA Label Image

Emperical-formula (Emprical Formula)

Chemical structure diagram depicting the amino acid sequence of glucagon. The structure shows a chain of 29 amino acids labeled from His at the N-terminus to Thr at the C-terminus, representing the peptide sequence of the glucagon molecule.*

FDA Label Image

Figure-01 (Figure 01)

A line graph depicting blood glucose concentrations (mg/dL) over time (hours). Blood glucose rises sharply, peaking before 1 hour, then declines and levels off around 80 mg/dL from approximately 1.5 to 4 hours. Error bars are shown at each data point.*

FDA Label Image

Figure-02 (Figure 02)

A line chart depicting glucagon concentration (ng/mL) over time (hours). The y-axis measures glucagon concentration from 0 to 10 ng/mL, while the x-axis spans 0 to 4 hours. Data points with error bars track the rise and fall of glucagon concentration, peaking near 1 hour before declining.*

FDA Label Image

Figure-a (Figure A)

An instructional line diagram labeled Figure A showing the components of a Glucagon kit by Cipla USA Inc. It illustrates a vial containing powder with a rubber stopper and flip-off seal, a needle protector and attached needle, and a prefilled syringe containing diluent with a backstop, plastic clip, and plunger.*

FDA Label Image

Figure-b (Figure B)

Instructional illustration showing a hand holding a device with the thumb applying force to a component, indicated by an upward arrow. Labeled as Figure B, this figure likely demonstrates a step in the use of the Glucagon kit by Cipla USA Inc.*

FDA Label Image

Figure-c (Figure C)

An instructional line drawing showing hands preparing an injection by drawing liquid from a vial into a syringe. The image is labeled as Figure C and includes an arrow indicating the syringe plunger being pulled back to withdraw fluid.*

FDA Label Image

Figure-d (Figure D)

An instructional illustration labeled Figure D showing a hand gripping and rotating a small rectangular object clockwise, indicated by a curved arrow below the hand.*

FDA Label Image

Figure-e (Figure E)

An instructional illustration showing a hand holding a vial and syringe, with a downward arrow indicating the direction or action to be taken. The image is labeled as Figure E and appears to demonstrate part of a medication preparation or administration process.*

FDA Label Image

Front-label-kit-pack (Front Label Kit Pack)

Glucagon for Injection, USP Emergency Kit for Low Blood Sugar by Cipla USA Inc. The kit contains Glucagon for Injection at 1 mg per vial and a diluent for use with a 1 mL syringe. The label includes instructions to reconstitute vial contents with the diluent. Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.